Scientists probe Cortisol's role in rare fat disease

NCT ID NCT04845165

First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 23 times

Summary

This study looked at how the body handles the hormone cortisol in people with a rare genetic condition called familial partial lipodystrophy type 2 (FPL2). The goal was to see if a specific enzyme that reactivates cortisol is more active in these patients, which might contribute to their severe metabolic issues. Researchers measured cortisol-related substances in urine and fat tissue from 25 participants. The study did not test any treatment, but aimed to better understand the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL PARTIAL LIPODYSTROPHY TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hop Claude Huriez

    Lille, 59037, France

Conditions

Explore the condition pages connected to this study.